Wang Xinxin - California Institute for Biomedical Research

基本信息

浏览量：17

职业迁徙

个人简介

暂无内容

研究兴趣

论文共 37 篇作者统计合作学者相似作者

按年份排序按引用量排序主题筛选期刊级别筛选合作者筛选合作机构筛选

CD7 targeted “off-the-shelf” CAR-T demonstrates robust in vivo expansion and high efficacy in the treatment of patients with relapsed and refractory T cell malignancies

Shiqi Li,Xinxin Wang,Lin Liu,Jia Liu,Jun Rao,Zhongtao Yuan,Li Gao,Yu Li,Le Luo, Gui Li,Zhimin Li, Sheng Li,Jiaping He,Lihua Zhang,Lvzhe Chen, Wenhui Huang,Ping Yin, Chunmin Li,Xiaoping Li,Youcheng Wang,Yancheng Dong,Dingsong Zhang, Qingying Zang,Yingnian Chen,Lianjun Shen, Wenling Li,Wei Cao,Xi Zhang,Sanbin Wang

Leukemiano. 11 (2023): 2176-2186

引用0浏览0WOSNATURE引用

248 SMART CAR-T cells resist tumor immunosuppressive microenvironment with enhanced efficacy against solid tumors

Tao Wang,Qi Dong,William Cao, Di Wu,Xinxin Wang,Wenjie Yin,Manli Yin,Lianjun Shen

Journal for ImmunoTherapy of Cancerno. Suppl 1 (2023)

引用0浏览0引用

Abstract CT196: Early Results of a Safety and Efficacy Study of Allogeneic TruUCAR™ GC502 in Patients with Relapsed/refractory B-cell Acute Lymphoblastic Leukemia (r/r B-ALL)

Shiqi Li,Xinxin Wang,Zhongtao Yuan,Lin Liu,Yu Li,Jia Liu,Jiaping He,Zhimin Li, Wei Zhao,Jianning Ge,Yajin Ni,Lianjun Shen, Wei Cao,Xi Zhang,Martina Sersch,Sanbin Wang

Cancer Researchno. 12_Supplement (2022)

引用0浏览0引用

P370: EARLY RESULTS OF A SAFETY AND EFFICACY STUDY OF ALLOGENEIC TRUUCAR™ GC502 IN PATIENTS WITH RELAPSED/REFRACTORY B-CELL ACUTE LYMPHOBLASTIC LEUKEMIA (R/R B-ALL)

Shiqi Li,Xinxin Wang,Zhongtao Yuan,Lin Liu,Yu Li,Jia Liu,Jiaping He,Zhimin Li,Wei Zhao,Jianning Ge,Yajin Ni,Lianjun Shen, Wei Cao,Xi Zhang,Martina Sersch,Sanbin Wang

HemaSphere（2022）

引用0浏览0引用

110 IL-2 Variant Improves CAR-T Functionality and Efficacy Against Solid Tumors

Tao Wang,Qi Dong, Ping Wang,Xinxin Wang,Wenjie Yin,Pengfei Jiang,Manli Yin,William Wei Cao,Lianjun Shen

Regular and Young Investigator Award Abstractsno. Suppl 2 (2021): A120-A120

引用1浏览0引用

Preclinical Results of an Allogeneic, Universal CD19/CD7-Targeting CAR-T Cell Therapy (GC502) for B Cell Malignancies

Jianning Ge,Chunhui Yang, Jing Sun, Jiao Chen, Shuyi Qiu,Wenjie Yin,Lianjun Shen,Martina Sersch,Wei Cao,Xinxin Wang

Blood（2021）

引用3浏览0引用

Continuation Versus Discontinuation of Aspirin-Based Antiplatelet Therapy for Perioperative Bleeding and Ischaemic Events in Adults Undergoing Neurosurgery: Protocol for a Systematic Review and Meta-Analysis

Xinyan Wang,Xinxin Wang,Yun Yu,Ruquan Han

BMJ open（2021）

引用4浏览0引用

Identification of FABP5 As an Immunometabolic Marker in Human Hepatocellular Carcinoma

Fangming Liu,Weiren Liu,Shuang Zhou,Chunhui Yang,Mengxin Tian,Guangshuai Jia,Han Wang,Bijun Zhu,Mingxiang Feng,Yan Lu,Tiankui Qiao,Xinxin Wang,Wei Cao,Xiangdong Wang,Yinghong Shi,Duojiao Wu

Journal for immunotherapy of cancer（2020）

引用26浏览0WOS引用

加载更多

作者统计

合作学者

合作机构

D-Core

合作者
学生
导师

暂无相似学者，你可以通过学者研究领域进行搜索筛选

数据免责声明

页面数据均来自互联网公开来源、合作出版商和通过AI技术自动分析结果，我们不对页面数据的有效性、准确性、正确性、可靠性、完整性和及时性做出任何承诺和保证。若有疑问，可以通过电子邮件方式联系我们：report@aminer.cn